Key result
A novel 9-item lifestyle screener yields high patient comfort for sharing information in T2D.
Why the study?
Clinical application of existing lifestyle behavior screening measures has been limited by their length and narrow diagnosis- or culture-specific focus.
Cross-Sectional (n=135)
A newly developed brief lifestyle behavior screening tool demonstrated high acceptability and feasibility among providers and patients with type 2 diabetes.
May facilitate lifestyle discussions in T2D visits; leaves open effects on adherence and outcomes.
Introduction and Objective: Lifestyle behaviors (LB) have gained widespread acceptance as a key component of diabetes management since first featured in the 2017 ADA Standard of Care, with emphasis on modifiable LB and practical screening tools to optimize diabetes prevention and management. However, clinical application of existing screening measures remains limited by their length and narrow diagnosis- or culture-specific focus. This study aimed to develop a brief LB screening tool that incorporates ADA and AHA lifestyle recommendations and maximizes utility across clinical settings and disciplines. Methods: The initial 9 items were generated from the ADA and AHA LB recommendations on diet, exercise, sleep, smoking, alcoholic drinks, and stress management. Stakeholders were engaged through clinical provider interviews (n=7) and type 2 diabetes (T2D) patient surveys (n=135, age (M=51.7 yrs, SD=7.4), 67% Female) to assess acceptability and feasibility. Items were revised after rounds of provider engagements. Results: The screening tool underwent iterative implementation cycles through field testing with lifestyle coaches for patients with T2D. Providers reported high content validity, gave recommendations on scoring benchmarks, and noted barriers and facilitators to implementation. On a Likert scale of not at all (1) to extremely (5), T2D patients reported being very comfortable sharing LB information with their providers (M=4.2, SD=0.9). People with T2D anticipate their providers would use LB screening to address specific health concerns (40%) and overall health (28%), as well as encourage healthy behaviors (18%); however, 14% of the sample reported being unsure of how a provider would use the information. Conclusion: Results demonstrate a high need for a clinically relevant LB screening tool that can be easily implemented into specialty and primary care settings. Clinicians requested results that facilitate longitudinal monitoring of behavior change and support modifiable LB recommendations with meaningful, validated cutoff scores. Disclosure A. Roebuck: None. C. Logan Delaney: None. K. Launer: None. J. Berndt: None. D. Albright: None. Funding Parkview Foundation (7054)
No takes yet. Share an insight, caveat, or question.
ROEBUCK et al. (2026) conducted a cross-sectional in Type 2 diabetes (n=135). Lifestyle Behavior Screener was evaluated on Acceptability and feasibility of the screening tool. A newly developed 9-item Lifestyle Behavior Screener was well-received, with type 2 diabetes patients reporting high comfort sharing lifestyle information with providers (mean score 4.2 out of 5).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: